140 related articles for article (PubMed ID: 32215377)
1. Perking Up Strategies to Control Restenosis.
Riascos-Bernal DF
JACC Basic Transl Sci; 2020 Mar; 5(3):264-266. PubMed ID: 32215377
[TBL] [Abstract][Full Text] [Related]
2. When under pressure, get closer: PERKing up membrane contact sites during ER stress.
van Vliet AR; Agostinis P
Biochem Soc Trans; 2016 Apr; 44(2):499-504. PubMed ID: 27068961
[TBL] [Abstract][Full Text] [Related]
3. Prospective randomized comparison of clinical and angiographic outcomes between everolimus-eluting vs. zotarolimus-eluting stents for treatment of coronary restenosis in drug-eluting stents: intravascular ultrasound volumetric analysis (RESTENT-ISR trial).
Hong SJ; Ahn CM; Kim BK; Ko YG; Hur SH; Yu CW; Lee SJ; Choi CU; Kim JS; Yoon JH; Hong YJ; Choi JW; Choi SH; Jang Y; Lim DS;
Eur Heart J; 2016 Dec; 37(45):3409-3418. PubMed ID: 27634828
[TBL] [Abstract][Full Text] [Related]
4. Differences in tissue characterization of restenotic neointima between sirolimus-eluting stent and bare-metal stent: integrated backscatter intravascular ultrasound analysis for in-stent restenosis.
Ando H; Amano T; Takashima H; Harada K; Kitagawa K; Suzuki A; Kunimura A; Shimbo Y; Harada K; Yoshida T; Kato B; Uetani T; Kato M; Matsubara T; Kumagai S; Yoshikawa D; Isobe S; Ishii H; Murohara T
Eur Heart J Cardiovasc Imaging; 2013 Oct; 14(10):996-1001. PubMed ID: 23341147
[TBL] [Abstract][Full Text] [Related]
5. Restenosis, Stent Thrombosis, and Bleeding Complications: Navigating Between Scylla and Charybdis.
Torrado J; Buckley L; Durán A; Trujillo P; Toldo S; Valle Raleigh J; Abbate A; Biondi-Zoccai G; Guzmán LA
J Am Coll Cardiol; 2018 Apr; 71(15):1676-1695. PubMed ID: 29650125
[TBL] [Abstract][Full Text] [Related]
6. Reduction of endoplasmic reticulum stress inhibits neointima formation after vascular injury.
Ishimura S; Furuhashi M; Mita T; Fuseya T; Watanabe Y; Hoshina K; Kokubu N; Inoue K; Yoshida H; Miura T
Sci Rep; 2014 Nov; 4():6943. PubMed ID: 25373918
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory effects of ASP6537, a selective cyclooxygenase-1 inhibitor, on thrombosis and neointima formation in rats.
Sakata C; Kawasaki T; Iwatsuki Y; Moritani Y; Morita Y; Hara H
Thromb Res; 2017 Sep; 157():72-78. PubMed ID: 28700965
[TBL] [Abstract][Full Text] [Related]
8. Tissue characteristics of neointima in late restenosis: integrated backscatter intravascular ultrasound analysis for in-stent restenosis.
Ando H; Suzuki A; Sakurai S; Kumagai S; Kurita A; Waseda K; Takashima H; Amano T
Heart Vessels; 2017 May; 32(5):531-538. PubMed ID: 27730297
[TBL] [Abstract][Full Text] [Related]
9. The Role of Tauroursodeoxycholic Acid on Dedifferentiation of Vascular Smooth Muscle Cells by Modulation of Endoplasmic Reticulum Stress and as an Oral Drug Inhibiting In-Stent Restenosis.
Luo H; Zhou C; Chi J; Pan S; Lin H; Gao F; Ni T; Meng L; Zhang J; Jiang C; Ji Z; Lv H; Guo H
Cardiovasc Drugs Ther; 2019 Feb; 33(1):25-33. PubMed ID: 30663009
[TBL] [Abstract][Full Text] [Related]
10. PERK Inhibition Mitigates Restenosis and Thrombosis: A Potential Low-Thrombogenic Antirestenotic Paradigm.
Wang B; Zhang M; Urabe G; Huang Y; Chen G; Wheeler D; Dornbos DJ; Huttinger A; Nimjee SM; Gong S; Guo LW; Kent KC
JACC Basic Transl Sci; 2020 Mar; 5(3):245-263. PubMed ID: 32215348
[TBL] [Abstract][Full Text] [Related]
11. IFN-γ aggravates neointimal hyperplasia by inducing endoplasmic reticulum stress and apoptosis in macrophages by promoting ubiquitin-dependent liver X receptor-α degradation.
Zhao Q; Zhou D; You H; Lou B; Zhang Y; Tian Y; Guo N; Chen X; Liu Y; Wu Y; Yuan Z; Zhou J
FASEB J; 2017 Dec; 31(12):5321-5331. PubMed ID: 28798155
[TBL] [Abstract][Full Text] [Related]
12. PERKing up the ER stress response.
Haucke V
Trends Cell Biol; 1999 Apr; 9(4):129. PubMed ID: 10203786
[No Abstract] [Full Text] [Related]
13. Do statins have a role in reduction/prevention of post-PCI restenosis?
Prasad K
Cardiovasc Ther; 2013 Feb; 31(1):12-26. PubMed ID: 21967674
[TBL] [Abstract][Full Text] [Related]
14. Neointimal Modification With Scoring Balloon and Efficacy of Drug-Coated Balloon Therapy in Patients With Restenosis in Drug-Eluting Coronary Stents: A Randomized Controlled Trial.
Kufner S; Joner M; Schneider S; Tölg R; Zrenner B; Repp J; Starkmann A; Xhepa E; Ibrahim T; Cassese S; Fusaro M; Ott I; Hengstenberg C; Schunkert H; Abdel-Wahab M; Laugwitz KL; Kastrati A; Byrne RA;
JACC Cardiovasc Interv; 2017 Jul; 10(13):1332-1340. PubMed ID: 28683939
[TBL] [Abstract][Full Text] [Related]
15. In stent restenosis and thrombosis assessment after EP224283 injection in a rat model.
Maurel B; Chai F; Maton M; Blanchemain N; Haulon S
Atherosclerosis; 2013 Aug; 229(2):462-8. PubMed ID: 23880206
[TBL] [Abstract][Full Text] [Related]
16. Local Hemodynamic Forces After Stenting: Implications on Restenosis and Thrombosis.
Ng J; Bourantas CV; Torii R; Ang HY; Tenekecioglu E; Serruys PW; Foin N
Arterioscler Thromb Vasc Biol; 2017 Dec; 37(12):2231-2242. PubMed ID: 29122816
[TBL] [Abstract][Full Text] [Related]
17. In-stent restenosis is associated with neointimal angiogenesis and macrophage infiltrates.
Zhang M; Cresswell N; Tavora F; Mont E; Zhao Z; Burke A
Pathol Res Pract; 2014 Dec; 210(12):1026-30. PubMed ID: 24815534
[TBL] [Abstract][Full Text] [Related]
18. Thrombospondin-4 ablation reduces macrophage recruitment in adipose tissue and neointima and suppresses injury-induced restenosis in mice.
Lv L; Liang W; Ye M; Zhang J; Zhang H; Xue G; Zhang L
Atherosclerosis; 2016 Apr; 247():70-7. PubMed ID: 26868511
[TBL] [Abstract][Full Text] [Related]
19. The role of integrated backscatter intravascular ultrasound in characterizing bare metal and drug-eluting stent restenotic neointima as compared to optical coherence tomography.
Sato K; Costopoulos C; Takebayashi H; Naganuma T; Miyazaki T; Goto K; Yamane H; Hagikura A; Kikuta Y; Taniguchi M; Hiramatsu S; Ito H; Colombo A; Haruta S
J Cardiol; 2014 Dec; 64(6):488-95. PubMed ID: 24794757
[TBL] [Abstract][Full Text] [Related]
20. SMYD3-PARP16 axis accelerates unfolded protein response and mediates neointima formation.
Long F; Yang D; Wang J; Wang Q; Ni T; Wei G; Zhu Y; Liu X
Acta Pharm Sin B; 2021 May; 11(5):1261-1273. PubMed ID: 34094832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]